APA (7th ed.) Citation

T, Z., JH, K., JS, S., JW, K., JT, K., CS, S., . . . M, Y. (2017). The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss. Oncotarget, 8(44), 76558. https://doi.org/10.18632/oncotarget.20576

Chicago Style (17th ed.) Citation

T, Zheng, Kang JH, Sim JS, Kim JW, Koh JT, Shin CS, Lim H, and Yim M. "The Farnesoid X Receptor Negatively Regulates Osteoclastogenesis in Bone Remodeling and Pathological Bone Loss." Oncotarget 8, no. 44 (2017): 76558. https://doi.org/10.18632/oncotarget.20576.

MLA (9th ed.) Citation

T, Zheng, et al. "The Farnesoid X Receptor Negatively Regulates Osteoclastogenesis in Bone Remodeling and Pathological Bone Loss." Oncotarget, vol. 8, no. 44, 2017, p. 76558, https://doi.org/10.18632/oncotarget.20576.